Ranbaxy Laboratories Ltd.
SET SMS ALERT
Ranbaxy Labs is not traded on BSE in the last 30 days
Ranbaxy Labs is not traded on NSE in the last 30 days
- Quote
- CHARTS
- NEWS
- COMMENTS
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Top Trading Ideas
9 November 2018
buy UPL Nov Fut |
Entry Price (Rs) 732.00 |
Exit Price (Rs) 738.50 |
Gain (Rs) 7.00 |
buy LICHousingFin Nov Fut |
Entry Price (Rs) 434.15 |
Exit Price (Rs) 442.65 |
Gain (Rs) 9.00 |
| Days | BSE | NSE |
| 30 | ||
| 50 | ||
| 150 | ||
| 200 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Ranbaxy Labs
| Standalone | Dec'14 | Sep'14 | Jun'14 | Mar'14 |
| Net Sales | 956.52 | 1,272.69 | 2,116.98 | 1,224.59 |
| Other Income | 17.75 | 20.02 | 25.76 | 636.50 |
| PBDIT | -351.50 | -155.67 | 926.39 | -37.66 |
| Net Profit | -1,420.49 | -368.26 | 755.12 | 897.86 |
(In Rs Cr)
| Total Share Capital | 211.66 |
| Net Worth | 1,096.99 |
| Total Debt | 5,991.06 |
| Net Block | 2,012.14 |
| Investments | 4,080.88 |
| Total Assets | 7,088.06 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 589.55 | -1.07 | 678.80 | 434.80 | 141,452.19 |
| Aurobindo Pharm | 798.30 | -1.84 | 826.35 | 527.05 | 46,773.00 |
| Cipla | 531.90 | 0.97 | 678.00 | 508.10 | 42,831.36 |
| Piramal Enter | 2271.75 | -0.70 | 3302.55 | 1796.75 | 41,501.34 |
| Divis Labs | 1510.60 | -2.59 | 1562.35 | 978.50 | 40,101.68 |
| More » | |||||
| Sep' 14 | Jun' 14 | Mar' 14 | Dec' 13 | |
| Promoter | 63.37 | 63.40 | 63.41 | 63.41 |
| Public (FII + DII) | 35.21 | 34.18 | 35.11 | 34.93 |
| Others | 1.42 | 2.42 | 1.48 | 1.66 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| No Mutual Funds Holding the share |
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Ranbaxy Labs
Ranbaxy Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 36,598.55 crore.
The company management includes Tsutomu Une - Chairman, Arun Sawhney - Managing Director & CEO, Akihiro Watanabe - Director, Anthony H Wild - Director, Kazunori Hirokawa - Director, Rajesh V Shah - Director, Takashi Shoda - Director, Percy K Shroff - Director.
It is listed on the BSE with a BSE Code of 500359 and the NSE with an NSE Code of RANBAXY.
Its Registered office is at A-41, Industrial Area, Phase-VIII-A,,Sahibzada Ajit Singh Nagar Mohali,Punjab - 160071.
Their Registrars are Alankit Assignment Ltd.
